Title: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Authors: Pujade-Lauraine, Eric ×
Hilpert, Felix
Weber, Béatrice
Reuss, Alexander
Poveda, Andres
Kristensen, Gunnar
Sorio, Roberto
Vergote, Ignace
Witteveen, Petronella
Bamias, Aristotelis
Pereira, Deolinda
Wimberger, Pauline
Oaknin, Ana
Mirza, Mansoor Raza
Follana, Philippe
Bollag, David
Ray-Coquard, Isabelle #
Issue Date: 1-May-2014
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:32 issue:13 pages:1302-8
Article number: 10.1200/JCO.2013.51.4489
Abstract: In platinum-resistant ovarian cancer (OC), single-agent chemotherapy is standard. Bevacizumab is active alone and in combination. AURELIA is the first randomized phase III trial to our knowledge combining bevacizumab with chemotherapy in platinum-resistant OC.
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science